Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 2 of 5)

Case studies of spinal cord injury patients treated with CD34+ and mesenchymal stem cells harvested from human umbilical cord Wharton's jelly and cord blood, animal studies using mesenchymal stem cells, immunosuppression requirements in allogeneic stem cell treatments, intrathecal and intravenous administration of autologous bone marrow stem cells in spinal cord injury patients, and the role [...]

Neil Riordan PhD – Stem cell therapy for spinal cord injury (part 1 of 5)

Part 1: Dr. Riordan discusses mesenchymal stem cell sources from umbilical cord Wharton's jelly, stem cell expansion, therapeutic potential of umbilical cord mesenchymal stem cells vs. bone marrow mesenchymal stem cells, CD34+ hematopoietic stem cells from umbilical cord blood and the scientific rationale supporting stem cell treatment of spinal cord injury.

Non-controversial stem sells: rationale for clinical use: Neil Riordan, Ph.D. – (Miami)

Dr. Riordan discussed types of stem cells used in treatments with a focus on adipose and umbilical cord derived stem cells, including their roles in immune system modulation, inflammation reduction and tissue repair:Autoimmune diseases and spinal cord Injury are highlighted. Dr. Riordan is the Founder of the Stem Cell Institute in Panama City, Panama.

2012-11-29T23:27:28+00:00November 29th, 2012|Neil Riordan PhD, Video - Stem Cell Therapy|